Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) — The “AI in Life Science Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The AI in Life Science Market was valued at USD 12.43 Billion in 2024, and is expected to reach USD 29.30 Billion by 2030, rising at a CAGR of 15.32%
The Global AI in Life Science Market is being driven by the increasing demand for faster, more accurate drug discovery, personalized medicine, and optimized clinical trials. AI technologies enable life science companies to analyze vast datasets, accelerating the identification of potential drug candidates and improving research efficiency.
AI’s ability to uncover hidden patterns in genomic, clinical, and medical data also facilitates the development of personalized treatment plans, enhancing patient outcomes. AI-driven automation is transforming research and development workflows, reducing costs and time-to-market for new therapies. The rise in chronic diseases and an aging global population further amplify the need for innovative solutions. With continuous advancements in machine learning and data analytics, AI is playing a crucial role in revolutionizing the life sciences industry.
Increasing Demand for Personalized Medicine
The growing need for personalized medicine is one of the primary drivers of the Global AI in Life Science Market. As healthcare continues to shift towards more individualized treatment approaches, AI plays a pivotal role in enabling this transformation. Personalized medicine tailors medical treatment to the specific characteristics of each patient, such as their genetic profile, lifestyle, and environment. This approach ensures that patients receive therapies that are most likely to be effective for their unique conditions, minimizing the trial-and-error process that has traditionally characterized medical treatments.
As the demand for personalized medicine increases, AI’s ability to analyze complex data and provide insights for more targeted treatments becomes even more crucial. This technology not only enables more effective and efficient healthcare but also holds the potential to significantly reduce healthcare costs, minimize adverse drug reactions, and improve overall patient outcomes. With continuous advancements in AI algorithms and data analytics, personalized medicine is expected to become more mainstream, propelling the growth of the AI in life sciences market.
AI for Precision Diagnostics and Imaging
Precision diagnostics and imaging are becoming more sophisticated with the integration of AI technologies, driving the Global AI in Life Science Market further. AI algorithms are increasingly being used to enhance diagnostic accuracy, particularly in medical imaging, which is a cornerstone of precision medicine. AI’s ability to analyze medical images – such as MRI scans, CT scans, and X-rays – allows healthcare providers to detect diseases early and accurately, often identifying issues that may be missed by human radiologists.
Increasing Demand for Healthcare Automation
The demand for healthcare automation is rising rapidly, and AI is a key enabler in this transformation. Automation in the life sciences industry aims to streamline administrative tasks, clinical workflows, and research processes, ultimately reducing operational costs and improving overall efficiency. AI-driven automation tools are already being utilized to handle routine tasks such as patient data entry, medical record management, appointment scheduling, and even regulatory compliance monitoring.
Expanding Applications in Genomics and Precision Medicine
The expanding applications of AI in genomics are significantly contributing to the growth of the Global AI in Life Science Market. Genomics, the study of genes and their functions, is at the forefront of personalized medicine. AI technologies are being leveraged to analyze vast amounts of genomic data and uncover insights that were previously beyond reach. This ability to process large-scale genomic datasets quickly and accurately is revolutionizing drug discovery, disease diagnosis, and treatment planning.
Lack of Standardization
Lack of standardization in data formats, clinical practices, and AI algorithms is another challenge hindering the growth of the Global AI in Life Science Market. The healthcare and life sciences industries are complex and fragmented, with various stakeholders using different systems, platforms, and protocols. This lack of standardization makes it difficult for AI systems to integrate seamlessly into existing healthcare infrastructures and analyze data from multiple sources. The inconsistency in how data is collected, stored, and shared between healthcare providers, research institutions, and AI companies can result in suboptimal performance of AI systems and reduced trust in their outcomes.
High Costs of Implementation and Integration
The high costs of implementing and integrating AI solutions into existing healthcare and life science systems present a significant barrier for many organizations. While AI has the potential to drive efficiency and reduce long-term costs, the initial investment required for purchasing AI tools, training staff, and ensuring system compatibility can be prohibitive. This includes the costs of procuring high-quality datasets, setting up advanced computing infrastructure, and ensuring compliance with regulatory requirements.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $12.43 Billion |
| Forecasted Market Value (USD) by 2030 | $29.3 Billion |
| Compound Annual Growth Rate | 15.3% |
| Regions Covered | Global |
Report Scope:
Key Market Players
- IBM Corporation
- Atomwise Inc.
- Nuance Communications, Inc.
- NuMedii, Inc.
- AiCure LLC
- Apixio Holdings, LLC
- Insilico Medicine
- Enlitic, Inc.
- Sensely, Inc.
- SINEQUA Group
AI In Life Science Market, By Offering:
AI In Life Science Market, By Deployment:
AI In Life Science Market, By Application:
- Medical Diagnosis
- Drug Discovery
- Precision & Personalized Medicine
- Biotechnology
- Clinical Trials
- Patent Monitoring
AI In Life Science Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global AI in Life Science Market Outlook
6. North America AI in Life Science Market Outlook
7. Europe AI in Life Science Market Outlook
8. Asia-Pacific AI in Life Science Market Outlook
9. South America AI in Life Science Market Outlook
10. Middle East and Africa AI in Life Science Market Outlook
11. Market Dynamics
12. Market Trends & Developments
13. Porter’s Five Forces Analysis
14. Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/fsuzbi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- AI in Life Science Market
